Company Overview of MedImmune Ventures, Inc.
Peter S. Greenleaf
Chief Executive Officer and Director, Sucampo Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 2 Board Members in 2 different organizations across 7 different industries.|
See Board Relationships
As of Fiscal Year 2014
One MedImmune WayPhone: 301-398-3000
Gaithersburg, Maryland 20878
Board Members Memberships
Former Chief Executive Officer and Director
Chief Executive Officer and Director
Saint Joseph's University
Western Connecticut State University
|Howard W. Robin||Chief Executive Officer, President and Director|
|Mark R. Baker J.D.||Chief Executive Officer, Director and Member of Science & Strategy Committee|
Progenics Pharmaceuticals, Inc.
|Craig A. Wheeler||Chief Executive Officer, President and Executive Director|
Momenta Pharmaceuticals Inc.
|Douglas L. Drysdale||Chairman, Chief Executive Officer and President|
Pernix Therapeutics Holdings, Inc.
|--||Compensation as of Fiscal Year 2013.|